- Grant funding of $75,000 to each clinic is part of Teva’s $2
million, two-year commitment to support clinics’ innovative mental
and behavioral health programs tailored to meet community
needs
- Community Routes is a collaborative effort between Direct
Relief, the National Association of Free and Charitable Clinics
(NAFC) and Teva Pharmaceuticals to help advance quality mental
health care for underserved populations suffering from anxiety and
depression
Direct Relief, the National Association of Free and Charitable
Clinics (NAFC), and Teva Pharmaceuticals, a U.S. affiliate of Teva
Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today
announced the continued funding of 11 local free and charitable
clinics in the U.S. as part of a $2 million, two-year commitment,
through their collaborative Community Routes: Access to Mental
Health Care program that aims to advance access to healthcare for
uninsured patients seeking treatment for anxiety and
depression.
The second round of funding to the clinics in Florida, New
Jersey and California underscores the commitment by Teva and its
partners to expand access to mental health resources. The grants
will support further expansion of the clinics’ innovative
behavioral health services that are tailored to meet the cultural
and language needs of patients in their local communities,
including screening and services focused on trauma-informed care,
training, continued community outreach and partnership development,
new delivery sites, and continued trust-building among their
patients and communities.
“Teva’s continued support for mental health across the U.S.
builds on the past year’s success, connecting even more patients
with quality care,” said Thomas Tighe, CEO and President of Direct
Relief. “Over the past year, free clinics serving the most
vulnerable patients were able to use these resources as a force
multiplier for good. Direct Relief is privileged to work with these
clinics, the National Association of Free and Charitable Clinics,
and Teva, on this initiative that is again helping so many.”
"We know that a third of adults in the U.S. show symptoms of
anxiety, depression or both – and more than 5.5 million adults with
a mental illness are uninsured," said Sven Dethlefs, PhD, Executive
Vice President, North America Commercial at Teva. "Through this
partnership, we are able to help address the rising need for
community-based mental health care for uninsured and underserved
populations."
Nicole Lamoureux, President and CEO of NAFC said, “It is
imperative that we continue to prioritize investment into mental
health and behavioral programs. The funding from Community Routes
provides these indispensable and trailblazing clinics with the
momentum they need to create and expand mental health programs that
can address the needs of their local communities.”
By the numbers
Through Community Routes: Access to Mental Health Care program,
Teva is providing funds and broad portfolio of generic medicines to
help advance health equity and quality care for underserved
populations suffering from depression and anxiety. Within the
program’s first six months, the eleven grant recipients reached
over 22,000 patients within underserved communities, supporting
individuals already facing other challenges , including food
insecurity, low literacy, homelessness and disabilities.
Program impact includes the facilitation of more than 7,300
anxiety, depression and adverse childhood experiences (ACE)
screenings, over 400 staff/volunteer and community member
trainings, and nearly 20 community events across NJ, CA and FL.
“Without the grant funding, there would be no access to therapy
services. In a post COVID world, there has never been more need for
mental health services, both therapy and medication. We are making
a difference because of the grant.” said Greg Speed, Counselor at
Cape Volunteers in Medicine in Cape May Court House, New
Jersey.
Visit TevaUSA.com to learn more about the Community Routes
program, including a video highlighting the many voices behind the
grassroots-focused program.
The 2023 grantee clinic recipients to receive continued funding
through Community Routes are outlined below with an overview of
their recent focus and impact made in their local communities
to-date.
FLORIDA
- University of Florida Mobile Outreach in Gainesville,
Florida - Create and disseminate evidence-informed, easily
accessible mental health wellness curriculum and training to
underserved populations via trusted community members through a
mobile outreach model.
- Grace Medical Home in Orlando, Florida - Expand an
existing program that proactively identifies trauma and offers
individualized interventions through an integrated, whole-person,
multi-disciplinary approach to improve health outcomes.
- Talbot House Ministries of Lakeland, Inc., in Lakeland,
Florida - Support medication reconciliation services provided
through the pharmacy, outreach and event coordination, and outreach
to homeless encampments to connect with clinical services and
referrals for mental health care, patient transportation, and
education.
NEW JERSEY
- Cape Volunteers in Medicine in Cape May Court House, New
Jersey - Improve mental and behavioral health access and
treatment among at-risk populations by expanding depression and
anxiety screenings. Funding also supports community events and
outreach to identify community members' mental and physical
needs.
- Bergen Volunteer Medical Initiative, Inc., in Hackensack,
New Jersey - Increase capacity and fill a much-needed gap in
care for Spanish-speaking patients with depression and anxiety
through the support of a bilingual mental health practitioner and
telehealth services to help reduce stigma and barriers to
care.
- Parker Family Health Center in Red Bank, New Jersey -
Support a collaboration with the Mental Health Association of
Monmouth County, which allows for a bilingual therapist to offer
weekly counseling and the creation of mental health education to be
shared at live community events, virtually, and digitally.
CALIFORNIA
- Samaritan House in San Mateo, California - Support
implementation of best practices in treating depression, anxiety,
and trauma, as well as working with geriatric and immigrant
populations. The creation of a student-led trainee program to
expand group and individual services and the adoption of
psychoeducational books, in native languages, to help promote
awareness and reduce stigma.
- Symba Center in Apple Valley, California - Expand
partnership with local behavioral health services organization to
remove barriers and support successful, trauma-informed, mental and
behavioral health care at a homeless shelter site.
- Westminster Free Clinic in Thousand Oaks, California -
Offer a range of culturally and linguistically competent mental
health services, including individual and peer support, and a
training program that empowers parents to identify the early signs
of mental health issues.
- Lestonnac Free Clinic in Orange, California - Establish
protocols and formalize behavioral health program under a
Behavioral Health Program Manager to provide care through a
trauma-informed lens and create a mentorship program for behavioral
health interns from local colleges and universities.
- Savie Health in Lompoc, California - Create a screening
protocol for social determinants of health (SDOH), depression, and
anxiety and provide culturally sensitive resources and referrals to
help patients overcome barriers to mental health care.
About Direct Relief
A humanitarian organization committed to improving the health
and lives of people affected by poverty and emergencies, Direct
Relief delivers lifesaving medical resources throughout the U.S.
and world to communities in need—without regard to politics,
religion, or ability to pay. For more information, visit
https://www.DirectRelief.org.
About National Association of Free and Charitable
Clinics
National Association of Free and Charitable Clinics (NAFC) is
the only nonprofit 501c (3) organization whose mission is solely
focused on the issues and needs of the medically underserved
throughout the nation and the more than 1,400 Free and Charitable
Clinics that serve them. The NAFC has earned the Platinum Seal of
Transparency from GuideStar and a 4-star rating from Charity
Navigator. Founded in 2001 and headquartered near Washington, D.C.,
the NAFC is working to ensure that the medically underserved have
access to affordable quality health care and strives to be a
national voice promoting quality health care for all. For more
information about the NAFC, please visit www.nafcclinics.org.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has
been developing and producing medicines to improve people’s lives
for more than a century. We are a global leader in generic and
innovative medicines with a portfolio consisting of over 3,500
products in nearly every therapeutic area. Around 200 million
people around the world take a Teva medicine every day, and are
served by one of the largest and most complex supply chains in the
pharmaceutical industry. Along with our established presence in
generics, we have significant innovative research and operations
supporting our growing portfolio of innovative and
biopharmaceutical products. Learn more at www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, which are based on management’s current beliefs and
expectations and are subject to substantial risks and
uncertainties, both known and unknown, that could cause our future
results, performance or achievements to differ significantly from
that expressed or implied by such forward-looking statements. You
can identify these forward-looking statements by the use of words
such as “should,” “expect,” “anticipate,” “estimate,” “target,”
“may,” “project,” “guidance,” “intend,” “plan,” “believe” and other
words and terms of similar meaning and expression in connection
with any discussion of future operating or financial performance.
Important factors that could cause or contribute to such
differences include risks relating to: our ability to continue
funding 11 local free and charitable clinics in the U.S. through
collaborative access to mental healthcare programs; our ability to
successfully compete in the marketplace, including: that we are
substantially dependent on our generic products; concentration of
our customer base and commercial alliances among our customers;
delays in launches of new generic products; the increase in the
number of competitors targeting generic opportunities and seeking
U.S. market exclusivity for generic versions of significant
products; our ability to successfully launch and execute our new
strategy, including to expand our innovative and biosimilar
medicines pipeline and profitably commercialize the innovative
medicines and biosimilar portfolio, whether organically or through
business development, and to sustain and focus our portfolio of
generics medicines; our substantial indebtedness; our business and
operations in general, including: the impact of global economic
conditions and other macroeconomic developments and the
governmental and societal responses thereto; compliance, regulatory
and litigation matters, including: failure to comply with complex
legal and regulatory environments; other financial and economic
risks; and other factors discussed in this press release, in our
Quarterly Report on Form 10-Q for the second quarter of 2023 and in
our Annual Report on Form 10-K for the year ended December 31,
2022, including in the sections captioned "Risk Factors” and
“Forward Looking Statements.” Forward-looking statements speak only
as of the date on which they are made, and we assume no obligation
to update or revise any forward-looking statements or other
information contained herein, whether as a result of new
information, future events or otherwise. You are cautioned not to
put undue reliance on these forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231025553870/en/
Direct Relief Tony Morain TMorain@directrelief.org
NAFC Kerry Thompson kerry@nafcclinics.org
Teva Yonatan Beker Yonatan.Beker@tevapharm.com
Teva Pharmaceutical Indu... (NYSE:TEVA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024